Ibio Historical Financial Ratios
| IBIO Stock | USD 2.94 0.31 11.79% |
Ibio is lately reporting on over 107 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 0.34 or Days Sales Outstanding of 1.1 K will help investors to properly organize and evaluate Ibio Inc financial condition quickly.
Ibio |
About Ibio Financial Ratios Analysis
Ibio IncFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Ibio investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Ibio financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Ibio history.
Ibio Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Ibio Inc stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Ibio sales, a figure that is much harder to manipulate than other Ibio Inc multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Stock Based Compensation To Revenue
A metric that compares the total value of stock-based compensation granted by a company to its total revenue, indicating how much of the revenue is used to compensate employees with stock options or awards.Average Inventory
The average amount of inventory a company holds over a certain period, which is used to calculate inventory turnover and efficiency in managing stock levels.Most ratios from Ibio's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Ibio Inc current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ibio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. At this time, Ibio's Average Inventory is very stable compared to the past year. As of the 30th of November 2024, Research And Ddevelopement To Revenue is likely to grow to 21.78, while Price To Sales Ratio is likely to drop 37.39.
| 2023 | 2024 (projected) | Dividend Yield | 0.0744 | 0.0662 | Price To Sales Ratio | 39.36 | 37.39 |
Ibio fundamentals Correlations
Click cells to compare fundamentals
Ibio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Ibio fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 159.18 | 124.59 | 23.79 | 34.22 | 39.36 | 37.39 | |
| Ptb Ratio | 4.61 | 2.72 | 0.89 | 0.49 | 0.36 | 0.34 | |
| Days Sales Outstanding | 1.3K | 850.69 | 934.33 | 1.2K | 1.0K | 1.1K | |
| Book Value Per Share | 240.99 | 277.49 | 145.59 | 25.12 | 5.57 | 5.29 | |
| Free Cash Flow Yield | (0.0556) | (0.12) | (0.87) | (4.84) | (2.44) | (2.31) | |
| Operating Cash Flow Per Share | (56.81) | (76.84) | (85.95) | (49.71) | (4.84) | (5.09) | |
| Stock Based Compensation To Revenue | 0.24 | 0.67 | 1.84 | 9.06 | 8.15 | 8.56 | |
| Capex To Depreciation | 0.51 | 2.14 | 3.07 | 4.16 | 0.17 | 0.16 | |
| Pb Ratio | 4.61 | 2.72 | 0.89 | 0.49 | 0.36 | 0.34 | |
| Ev To Sales | 145.62 | 105.74 | 25.94 | (9.11) | (10.48) | (9.95) | |
| Free Cash Flow Per Share | (61.73) | (90.03) | (112.62) | (59.08) | (4.9) | (5.14) | |
| Roic | (0.87) | (5.9) | (0.28) | (0.98) | (0.75) | (0.78) | |
| Net Income Per Share | (80.53) | (59.45) | (116.97) | (47.87) | (6.5) | (6.83) | |
| Sales General And Administrative To Revenue | 7.59 | 9.29 | 14.32 | 51.88 | 46.7 | 49.03 | |
| Research And Ddevelopement To Revenue | 1.96 | 4.21 | 7.44 | 23.04 | 20.74 | 21.78 | |
| Capex To Revenue | 0.7 | 2.18 | 4.88 | 0.93 | 0.84 | 1.02 | |
| Cash Per Share | 234.62 | 247.86 | 76.87 | 7.02 | 3.71 | 3.52 | |
| Pocfratio | (19.54) | (9.83) | (1.51) | (0.25) | (0.42) | (0.44) | |
| Interest Coverage | (5.68) | (12.68) | (35.19) | (96.71) | (87.04) | (91.39) | |
| Capex To Operating Cash Flow | (0.0865) | (0.17) | (0.31) | (0.19) | (0.0113) | (0.0119) | |
| Pfcf Ratio | (17.98) | (8.39) | (1.15) | (0.21) | (0.41) | (0.43) | |
| Income Quality | 0.81 | 1.3 | 0.75 | 0.47 | 0.74 | 0.62 | |
| Roe | (0.33) | (0.21) | (0.8) | (1.91) | (1.17) | (1.23) | |
| Ev To Operating Cash Flow | (17.87) | (8.34) | (1.65) | (0.67) | 0.11 | 0.12 | |
| Pe Ratio | (13.78) | (12.7) | (1.11) | (0.25) | (0.31) | (0.32) | |
| Ev To Free Cash Flow | (7.2) | (16.45) | (7.12) | (1.26) | (0.56) | 0.11 | |
| Earnings Yield | (0.0725) | (0.0787) | (0.9) | (3.92) | (3.23) | (3.07) | |
| Intangibles To Total Assets | 0.0449 | 0.0121 | 0.006478 | 0.0488 | 0.13 | 0.34 | |
| Net Debt To E B I T D A | 1.89 | 2.44 | (0.2) | (0.45) | 0.7 | 0.73 | |
| Current Ratio | 11.79 | 15.74 | 1.48 | 1.22 | 4.08 | 3.7 | |
| Tangible Book Value Per Share | 236.12 | 275.06 | 134.47 | 16.32 | 4.16 | 3.96 | |
| Receivables Turnover | 0.29 | 0.43 | 0.39 | 0.32 | 0.36 | 0.34 | |
| Graham Number | 660.84 | 609.28 | 619.01 | 164.5 | 28.53 | 27.11 |
Pair Trading with Ibio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ibio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ibio will appreciate offsetting losses from the drop in the long position's value.Moving together with Ibio Stock
| 0.64 | ESPR | Esperion Therapeutics Buyout Trend | PairCorr |
| 0.84 | EWTX | Edgewise Therapeutics | PairCorr |
| 0.61 | BHC | Bausch Health Companies | PairCorr |
Moving against Ibio Stock
| 0.71 | ELAN | Elanco Animal Health | PairCorr |
| 0.61 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.54 | HLN | Haleon plc | PairCorr |
| 0.54 | TAK | Takeda Pharmaceutical | PairCorr |
| 0.38 | RDY | Dr Reddys Laboratories | PairCorr |
The ability to find closely correlated positions to Ibio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ibio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ibio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ibio Inc to buy it.
The correlation of Ibio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ibio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ibio Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ibio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ibio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ibio. If investors know Ibio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ibio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.03) | Revenue Per Share 0.059 | Quarterly Revenue Growth (0.88) | Return On Assets (0.30) | Return On Equity (0.84) |
The market value of Ibio Inc is measured differently than its book value, which is the value of Ibio that is recorded on the company's balance sheet. Investors also form their own opinion of Ibio's value that differs from its market value or its book value, called intrinsic value, which is Ibio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ibio's market value can be influenced by many factors that don't directly affect Ibio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ibio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ibio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ibio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.